Begin main content

CONSULTATION: Proposed Revisions to the pCODR Clinician Engagement Process

March 20, 2018
Deadline to Submit Feedback: April 20, 2018 at 5:00 p.m. ET by email to CADTH invites stakeholder feedback on proposed revisions to the clinician engagement process for its pan-Canadian Oncology Drug Review (pCODR) program. Below is a link to the consultation document. Proposed Revisions to the Clinician Engagement Process for...

2018 CADTH Symposium — Plenary Speakers

March 19, 2018
We are pleased to announce an outstanding lineup of Canadian and international plenary speakers at the 2018 CADTH Symposium in Halifax, Nova Scotia, April 15 to 17, 2018: John Abbott, Deputy Minister, Department of Health & Community Services, Government of Newfoundland and Labrador Maureen Allen, Emergency Medicine Physician Fiona Clement,...

2018 Call for Nominations

March 19, 2018
CADTH has released a Call for Nominations to attract qualified candidates to join our advisory and expert committees. We are seeking a number of new members, including patient, clinician, and public members who have a range of education, experience, and skill sets from across the country. This is an exciting opportunity to become involved in the...

Call for Patient Input: Nucynta

March 19, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Nucynta Brand name Generic name Manufacturer I...

New at CADTH — March 2018

March 16, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.